Physicians' Academy for Cardiovascular Education

Single infusions of MDCO-216 (ApoA1 Milano/POPC) were well tolerated in healthy volunteers and in patients with stable CAD

June 19, 2015

Presentation prepared and held by dr. David Kallend (Zürich, Switzerland) in Clinical Breakthroughs session: Modifying LDL cholesterol to prevent CV events, Tuesday, May 26, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images

ISA_2015_slides_Kallend_et_al.pdf (0,9MB)ISA_2015_slides_Kallend_et_al.pdf (0,9MB)